{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:27:38Z","timestamp":1763620058794},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/01.jaa.0000453233.24754.ec","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T13:11:08Z","timestamp":1407417068000},"page":"26-31","source":"Crossref","is-referenced-by-count":14,"title":["Gout"],"prefix":"10.1097","volume":"27","author":[{"given":"Eric","family":"Rymal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Rizzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar1906","article-title":"A concise history of gout and hyperuricemia and their treatment.","volume":"8","author":"Nuki","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10067-009-1362-1","article-title":"Clinical features of women with gout arthritis. A systematic review.","volume":"29","author":"Dirken-Heukensfeldt","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"10","key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrrheum.2012.144","article-title":"The genetics of hyperuricaemia and gout.","volume":"8","author":"Reginato","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","article-title":"Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.","volume":"3","author":"Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MNH.0b013e32835ddad2","article-title":"The kidney in hyperuricemia and gout.","volume":"22","author":"Mount","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-2-48","article-title":"Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.","volume":"2","author":"Torres","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/BOR.0b013e3283361ac0","article-title":"Unusual clinical presentations of gout.","volume":"22","author":"Ning","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"issue":"suppl 5","key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.3949\/ccjm.75.Suppl_5.S2","article-title":"The pathogenesis of gout.","volume":"75","author":"Schumacher","year":"2008","journal-title":"Cleve Clin J Med"},{"issue":"10","key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/ard.2006.063768","article-title":"Are joints affected by gout also affected by osteoarthritis.","volume":"66","author":"Roddy","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men.","volume":"350","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"e38123","DOI":"10.1371\/journal.pone.0038123","article-title":"The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study.","volume":"7","author":"Zaga","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1002\/art.34677","article-title":"Cherry consumption and decreased risk of recurrent gout attacks.","volume":"64","author":"Zhang","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"R15-5-20210130","first-page":"199","article-title":"Gout and its comorbidities.","volume":"68","author":"Pillinger","year":"2010","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"6","key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1751-7176.2012.00701.x","article-title":"Effect of allopurinol on blood pressure: a systematic review and meta-analysis.","volume":"15","author":"Agarwal","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"8","key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction.","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.rdc.2005.10.003","article-title":"Newer therapeutic approaches: gout.","volume":"32","author":"Schumacher","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"issue":"34-35","key":"R19-5-20210130","first-page":"549","article-title":"Goutcurrent diagnosis and treatment.","volume":"106","author":"Tausche","year":"2009","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"R22-5-20210130","first-page":"801","article-title":"Gout: an update.","volume":"76","author":"Eggebeen","year":"2007","journal-title":"Am Fam Physician"},{"issue":"8","key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.2005.049023","article-title":"Gout, diuretics and the kidney.","volume":"65","author":"Pascual","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/ar2687","article-title":"Imaging of gout: findings and utility.","volume":"11","author":"Perez-Ruiz","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/ar3489","article-title":"Imaging in goutwhat can we learn from MRI, CT, DECT and US.","volume":"13","author":"McQueen","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1136\/annrheumdis-2013-204108","article-title":"Usefulness of ultrasonography in the diagnosis of gout: a meta-analysis.","volume":"72","author":"Mathieu","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00256-010-1008-z","article-title":"Ultrasound features of tophi in chronic tophaceous gout.","volume":"40","author":"de Avila Fernandes","year":"2011","journal-title":"Skeletal Radiol"},{"issue":"6","key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/2040622312462056","article-title":"Latest evidence on gout management: what the clinician needs to know.","volume":"3","author":"Burns","year":"2012","journal-title":"Ther Adv Chronic Dis"},{"issue":"7","key":"R30-5-20210130","first-page":"E1","article-title":"Cochrane Musculoskeletal Group review: acute gout. Steroids or NSAIDs Let this overview from the Cochrane Group help you decide whats best for your patient.","volume":"58","author":"Winzenberg","year":"2009","journal-title":"J Fam Pract"},{"issue":"4","key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"10","key":"R32-5-20210130","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study.","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"7","key":"R33-5-20210130","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.144063","article-title":"Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.","volume":"70","author":"Schlesinger","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"R34-5-20210130","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"R35-5-20210130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/BOR.0b013e3283257b83","article-title":"Reassessing serum urate targets in the management of refractory gout: can you go too low.","volume":"21","author":"Hershfield","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"R36-5-20210130","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2978","article-title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.","volume":"12","author":"Becker","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"R37-5-20210130","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","article-title":"Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.","volume":"125","author":"Taylor","year":"2012","journal-title":"Am J Med"},{"issue":"suppl 5","key":"R38-5-20210130","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.3949\/ccjm.75.Suppl_5.S22","article-title":"The practical management of gout.","volume":"75","author":"Schumacher","year":"2008","journal-title":"Cleve Clin J Med"},{"issue":"7","key":"R39-5-20210130","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3899\/jrheum.111375","article-title":"Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.","volume":"39","author":"Strand","year":"2012","journal-title":"J Rheumatol"},{"issue":"7","key":"R40-5-20210130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"}],"container-title":["Journal of the American Academy of Physician Assistants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000453233.24754.ec","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:42:17Z","timestamp":1620931337000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01720610-201409000-00005"}},"subtitle":["A comprehensive review"],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000453233.24754.ec","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}